Table 1.
Behavioral responses to TPM, LZP, and PLA, relative to a no-treatment baseline, as captured by neuropsychological and speech measures.
Change score of TPM* from baseline |
Change score of LZP** from baseline |
Change score of PLA from baseline |
||||||
---|---|---|---|---|---|---|---|---|
Predicted group mean (SE) |
Test of change from baseline p value |
Predicted group mean (SE) |
Test of change from baseline p value |
Test of LZP vs. TPM p value |
Predicted group mean (SE) |
Test of change from baseline p value |
Test of PLA vs. TPM p value |
|
Gen. Verbal Fluency | ||||||||
Phonemic (FAS/BHR) | −0.24 (0.04) | <0.0001 | −0.05 (0.05) | 0.35 | 0.0031 | −0.003 (0.04) | 0.94 | <0.0001 |
Category | ||||||||
Animals/Clothing | −0.09 (0.06) | 0.10 | 0.13 (0.07) | 0.10 | 0.05 | −0.01 (0.06) | 0.83 | 0.47 |
Boy/Girl names | −0.24 (0.06) | 0.0002 | 0.05 (0.07) | 0.43 | 0.0006 | −0.02 (0.06) | 0.79 | 0.0009 |
Switching | −0.20 (0.05) | 0.0002 | 0.02 (0.07) | 0.80 | 0.04 | 0.002 (0.05) | 0.97 | 0.01 |
MCG IR 1 | ||||||||
Word Count | −0.14 (0.08) | 0.09 | −0.21 (0.12) | 0.08 | 0.88 | 0.08 (0.08) | 0.36 | 0.16 |
Correct Words | −0.21 (0.10) | 0.04 | −0.23 (0.14) | 0.11 | 0.99 | 0.24 (0.10) | 0.02 | 0.007 |
Disfluency rate | 0.11 (0.17) | 0.55 | −0.56 (0.22) | 0.01 | 0.01 | −0.09 (0.18) | 0.63 | 0.48 |
MCG IR 2 | ||||||||
Word Count | −0.19 (0.06) | 0.003 | −0.15 (0.08) | 0.06 | 0.90 | 0.13 (0.06) | 0.08 | 0.0003 |
Correct Words | −0.10 (0.07) | 0.16 | −0.30 (0.10) | 0.007 | 0.29 | 0.33 (0.07) | 0.0001 | 0.001 |
Disfluency rate | 0.04 (0.12) | 0.74 | −0.35 (0.17) | 0.04 | 0.12 | −0.19 (0.12) | 0.13 | 0.29 |
MCG Delayed Recall | ||||||||
Word Count | −0.08 (0.07) | 0.30 | −0.18 (0.10) | 0.09 | 0.69 | 0.12 (0.07) | 0.11 | 0.13 |
Correct Words | −0.09 (0.08) | 0.28 | −0.27 (0.12) | 0.04 | 0.49 | 0.37 (0.08) | 0.0001 | 0.001 |
Disfluency rate | 0.32 (0.26) | 0.22 | −0.15 (0.30) | 0.61 | 0.11 | 0.11 (0.26) | 0.68 | 0.44 |
Picture Descript-Standard | ||||||||
Word Count | 0.14 (0.08) | 0.11 | 0.10 (0.12) | 0.39 | 0.96 | 0.17 (0.09) | 0.07 | 0.98 |
Correct Information Units | 0.27 (0.09) | 0.004 | 0.15 (0.11) | 0.19 | 0.52 | 0.25 (0.09) | 0.008 | 0.97 |
Disfluency rate | 0.66 (0.24) | 0.01 | 0.14 (0.26) | 0.59 | 0.009 | 0.16 (0.24) | 0.51 | 0.002 |
Picture Descript-MAPDS | ||||||||
Word Count | 0.002 (0.11) | 0.99 | 0.19 (0.13) | 0.14 | 0.20 | 0.19 (0.11) | 0.09 | 0.08 |
Correct Information Units | −0.02 (0.09) | 0.81 | −0.02 (0.13) | 0.85 | 1.00 | 0.19 (0.10) | 0.07 | 0.14 |
Disfluency rate | 1.12 (0.83) | 0.19 | 0.80 (0.84) | 0.35 | 0.12 | 0.89 (0.83) | 0.29 | 0.15 |
TPM, topiramate; LZP, lorazepam; PLA, placebo
IR1, immediate recall 1; IR2, immediate recall 2
N= 20
LZP was only administered to UMN participants only (N=11)